Structure and function of the human calcium-sensing receptor: Insights from natural and engineered mutations and allosteric modulators: Ca2+-Sensing Receptor Review Series

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 5, 2007, Pages 908-922

  Hu, Jianxin ^a   Spiegel, Allen M ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Allosteric modulators; G protein coupled receptor; Hypercalcaemia; Hypocalcaemia; Receptor mutations

Indexed keywords

CALCIUM SENSING RECEPTOR;

ALLOSTERISM; AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; GENETICS; HUMAN; HYPERPARATHYROIDISM; METABOLISM; MOLECULAR GENETICS; MUTAGENESIS; MUTATION; STRUCTURE ACTIVITY RELATION;

ALLOSTERIC REGULATION; AMINO ACID SEQUENCE; HUMANS; HYPERPARATHYROIDISM; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTATION; RECEPTORS, CALCIUM-SENSING; STRUCTURE-ACTIVITY RELATIONSHIP;

DIONAEA;

EID: 35648991976     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00096.x     Document Type: Article

References (80)

1. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC. Cloning and characterization of an extra-cellular Ca(2+)-sensing receptor from bovine parathy-roid. Nature. 1993 366 : 575 80.
2. Hofer AM, Brown EM. Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol. 2003 4 : 530 8.
3. Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev. 2001 81 : 239 97.
4. Brown EM. Clinical lessons from the calcium-sensing receptor. Nat Clin Pract Endocrinol Metab. 2007 3 : 122 33.
5. 2+-sensing receptor: implications for its structure and function. Trends Endocrinol Metab. 2003 14 : 282 8.
6. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature. 2000 407 : 971 7.
7. Nemeth EF, Fox J. Calcimimetic compounds: a direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism. Trends Endocrinol Metab. 1999 10 : 66 71.
8. 2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther. 2001 299 : 323 31.
9. Nemeth EF, Heaton WH, Miller M, Fox J, Balandrin MF, Van Wagenen BC, Colloton M, Karbon W, Scherrer J, Shatzen E, Rishton G, Scully S, Qi M, Harris R, Lacey D, Martin D. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther. 2004 308 : 627 35.
10. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science. 2000 289 : 739 45.
11. Janicic N, Soliman E, Pausova Z, Seldin MF, Riviere M, Szpirer J, Szpirer C, Hendy GN. Mapping of the calcium-sensing receptor gene (casr) to human-chromosome 3q13.3-21 by fluorescence in-situ hybridization, and localization to rat chromosome-11 and mouse chromosome-16. Mammalian Genome. 1995 6 : 798 801.
12. Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, Nemeth EF, Fuller F. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem. 1995 270 : 12919 25.
13. Goldsmith PK, Fan GF, Ray K, Shiloach J, McPhie P, Rogers KV, Spiegel AM. Expression, purification, and biochemical characterization of the amino-terminal extracellular domain of the human calcium receptor. J Biol Chem. 1999 274 : 11303 9.
14. Ray K, Clapp P, Goldsmith PK, Spiegel AM. Identification of the sites of N-linked glycosylation on the human calcium receptor and assessment of their role in cell surface expression and signal transduction. J Biol Chem. 1998 273 : 34558 67.
15. Bai M, Quinn S, Trivedi S, Kifor O, Pearce SH, Pollak MR, Krapcho K, Hebert SC, Brown EM. Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. J Biol Chem. 1996 271 : 19537 45.
16. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, Brown EM, Seidman JG, Seidman CE. A mouse model of human familial hypocalciuric hyper-calcemia and neonatal severe hyperparathyroidism. Nat Genet. 1995 11 : 389 94.
17. Wettschureck N, Lee E, Libutti SK, Offermanns S, Robey PG, Spiegel AM. Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extra-cellular Ca2+ -sensing receptor. Mol Endocrinol. 2007 21 : 274 80.
18. Makita N, Sato J, Manaka K, Shoji Y, Oishi A, Hashimoto M, Fujita T, Iiri T. An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations. Proc Natl Acad Sci USA. 2007 104 : 5443 8.
19. Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC, Kos CH, Pollak MR, Brown EM, Scadden DT. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature. 2006 439 : 599 603.
20. Bockaert J, Pin JP. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 1999 18 : 1723 9.
21. O'Hara PJ, Sheppard PO, Thogersen H, Venezia D, Haldeman BA, McGrane V, Houamed KM, Thomsen C, Gilbert TL, Mulvihill ER. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron. 1993 11 : 41 52.
22. 2+ receptor extracellular domain. Analysis of function of lobe I loop deletion mutants. J Biol Chem. 2001 276 : 32145 51.
23. 3+. Proc Natl Acad Sci USA. 2002 99 : 2660 5.
24. 2+ receptor:effects on cell surface expression, dimerization and signal transduction. FEBS Lett. 1998 436 : 353 6.
25. 2+ receptor. J Biol Chem. 1999 274 : 27642 50.
26. Tsuji Y, Shimada Y, Takeshita T, Kajimura N, Nomura S, Sekiyama N, Otomo J, Usukura J, Nakanishi S, Jingami H. Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. J Biol Chem. 2000 275 : 28144 51.
27. Zhang Z, Sun S, Quinn SJ, Brown EM, Bai M. The extracellular calcium-sensing receptor dimerizes through multiple types of intermolecular interactions. J Biol Chem. 2001 276 : 5316 22.
28. Bai M, Trivedi S, Kifor O, Quinn SJ, Brown EM. Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. Proc Natl Acad Sci USA. 1999 96 : 2834 9.
29. 2+ receptor activation. Endocrine. 2000 13 : 63 70.
30. Brauner-Osborne H, Jensen AA, Sheppard PO, O'Hara P, Krogsgaard-Larsen P. The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain. J Biol Chem. 1999 274 : 18382 6.
31. 2+ binding pocket within the venus flytrap module of the human calcium-sensing receptor. J Biol Chem. 2005 280 : 37917 23.
32. Kniazeff J, Bessis AS, Maurel D, Ansanay H, Prezeau L, Pin JP. Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat Struct Mol Biol. 2004 11 : 706 13.
33. Muto T, Tsuchiya D, Morikawa K, Jingami H. Structures of the extracellular regions of the group II/III metabotropic glutamate receptors. Proc Natl Acad Sci USA. 2007 104 : 3759 64.
34. 2+ receptor. J Bone Miner Res. 2007 22 : 601 8.
35. 2+ receptor cysteine-rich domain. Analysis of function of mutant and chimeric receptors. J Biol Chem. 2000 275 : 16382 9.
36. 2+ receptor are not linked by disulfide bonds. J Biol Chem. 2001 276 : 6901 4.
37. Conklin BR, Bourne HR. Homeostatic signals. Marriage of the flytrap and the serpent. Nature. 1994 367 : 22.
38. 2+-sensing receptor mediate efficient coupling to phospholipase C. J Biol Chem. 2000 275 : 19955 63.
39. Tateyama M, Abe H, Nakata H, Saito O, Kubo Y. Ligand-induced rearrangement of the dimeric metabotropic glutamate receptor 1alpha. Nat Struct Mol Biol. 2004 11 : 637 42.
40. Malherbe P, Kratochwil N, Knoflach F, Zenner MT, Kew JN, Kratzeisen C, Maerki HP, Adam G, Mutel V. Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, non-competitive antagonist of the metabotropic glutamate 1 receptor. J Biol Chem. 2003 278 : 8340 7.
41. Malherbe P, Kratochwil N, Zenner MT, Piussi J, Diener C, Kratzeisen C, Fischer C, Porter RH. Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine. Mol Pharmacol. 2003 64 : 823 32.
42. 2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain. J Biol Chem. 2004 279 : 18990 7.
43. Miedlich SU, Gama L, Seuwen K, Wolf RM, Breitwieser GE. Homology modeling of the trans-membrane domain of the human calcium sensing receptor and localization of an allosteric binding site. J Biol Chem. 2004 279 : 7254 63.
44. Yohannan S, Faham S, Yang D, Whitelegge JP, Bowie JU. The evolution of transmembrane helix kinks and the structural diversity of G protein-coupled receptors. Proc Natl Acad Sci USA. 2004 101 : 959 63.
45. rd., Odelberg S, Jackson CE, Teh BT, Hayward N, Larsson C, Buist NR, Krapcho KJ, Hung BC, Capuano IV, Garrett JE, Leppert MF. Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalci-uric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab. 1996 81 : 1312 7.
46. 2+. J Biol Chem. 2005 280 : 5113 20.
47. Ray K, Fan GF, Goldsmith PK, Spiegel AM. The car-boxyl terminus of the human calcium receptor:require-ments for cell-surface expression and signal transduction. J Biol Chem. 1997 272 : 31355 61.
48. 2+ activation of the human calcium sensing receptor. A study with receptor-green fluorescent protein fusions. J Biol Chem. 1998 273 : 29712 8.
49. Hjalm G, Mac Leod RJ, Kifor O, Chattopadhyay N, Brown EM. Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem. 2001 276 : 34880 7.
50. 2+o-sensing receptor (CaR) modulates functional interaction of G proteins with the CaR cytoplasmic tail. J Biol Chem. 2002 277 : 50543 9.
51. Scillitani A, Guarnieri V, De Geronimo S, Muscarella LA, Battista C, D'Agruma L, Bertoldo F, Florio C, Minisola S, Hendy GN, Cole DE. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endocrinol Metab. 2004 89 : 5634 8.
52. Waller S, Kurzawinski T, Spitz L, Thakker R, Cranston T, Pearce S, Cheetham T, van't Hoff WG. Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr. 2004 163 : 589 94.
53. Kobayashi M, Tanaka H, Tsuzuki K, Tsuyuki M, Igaki H, Ichinose Y, Aya K, Nishioka N, Seino Y. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism. J Clin Endocrinol Metab. 1997 82 : 2716 9.
54. Pearce SHS, Bai M, Quin SJ, Kifor O, Brown EM, Thakker RV. Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J Clin Invest. 1996 98 : 1860 6.
55. 2+ sensing receptor gene:normal maternal calcium homeostasis as a cause of secondary hyperparathy-roidism in familial benign hypocalciuric hypercalcemia. J Clin Invest. 1997 99 : 88 96.
56. Marcocci C, Borsari S, Pardi E, Dipollina G, Giacomelli T, Pinchera A, Cetani F. Familial hypocal-ciuric hypercalcemia in a woman with metastatic breast cancer: a case report of mistaken identity. J Clin Endocrinol Metab. 2003 88 : 5132 6.
57. Yamauchi M, Sugimoto T, Yamaguchi T, Yano S, Wang J, Bai M, Brown EM, Chihara K. Familial hypocalciuric hypercalcemia caused by an R648stop mutation in the calcium-sensing receptor gene. J Bone Miner Res. 2002 17 : 2174 82.
58. Pidasheva S, Canaff L, Simonds WF, Marx SJ, Hendy GN. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide mis-sense mutations in familial hypocalciuric hypercal-cemia. Hum Mol Genet. 2005 14 : 1679 90.
59. de Andrade SC, Kohara SK, D'Souza-Li L. Novel mutation of the calcium sensing receptor gene in familial hypocalciuric hypercalcaemia and neonatal severe hyperparathyroidism. Clin Endocrinol. 2006 65 : 826 7.
60. 2+ receptor. FEBS Lett. 1999 448 : 180 4.
61. Vargas-Poussou R, Huang C, Hulin P, Houillier P, Jeunemaitre X, Paillard M, Planelles G, Dechaux M, Miller RT, Antignac C. Functional characterization of a calcium-sensing receptor mutation in severe autoso-mal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol. 2002 13 : 2259 66.
62. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet. 2002 360 : 692 4.
63. Lienhardt A, Garabedian M, Bai M, Sinding C, Zhang Z, Lagarde JP, Boulesteix J, Rigaud M, Brown EM, Kottler ML. A large homozygous or het-erozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J Clin Endocrinol Metab. 2000 85 : 1695 702.
64. Hu J, Mora S, Colussi G, Proverbio MC, Jones KA, Bolzoni L, De Ferrari ME, Civati G, Spiegel AM. Autosomal dominant hypocalcemia caused by a novel mutation in the loop 2 region of the human calcium receptor extracellular domain. J Bone Miner Res. 2002 17 : 1461 9.
65. 136 region in the calcium-sensing receptor. J Biol Chem. 2000 275 : 29547 55.
66. Patel AB, Crocker E, Eilers M, Hirshfeld A, Sheves M, Smith SO. Coupling of retinal isomerization to the activation of rhodopsin. Proc Natl Acad Sci USA. 2004 101 : 10048 53.
67. Conley YP, Finegold DN, Peters DG, Cook JS, Oppenheim DS, Ferrell RE. Three novel activating mutations in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia. Mol Genet Metab. 2000 71 : 591 8.
68. Pearce SH, Wooding C, Davies M, Tollefsen SE, Whyte MP, Thakker RV. Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pan-creatitis. Clin Endocrinol. 1996 45 : 675 80.
69. Hu J, Mora S, Weber G, Zamproni I, Proverbio MC, Spiegel AM. Autosomal dominant hypocalcemia in monozygotic twins caused by a de novo germline mutation near the amino-terminus of the human calcium receptor. J Bone Miner Res. 2004 19 : 578 86.
70. May LT, Avlani VA, Sexton PM, Christopoulos A. Allosteric modulation of G protein-coupled receptors. Curr Pharm Des. 2004 10 : 2003 13.
71. Nemeth EF, Steffey ME, Hammerland LG, Hung BC, Van Wagenen BC, DelMar EG, Balandrin MF. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA. 1998 95 : 4040 5.
72. Cohen A, Silverberg SJ. Calcimimetics: therapeutic potential in hyperparathyroidism. Curr Opin Pharmacol. 2002 2 : 734 9.
73. Zhang Z, Jiang Y, Quinn SJ, Krapcho K, Nemeth EF, Bai M. L-phenylalanine and NPS R-467 synergistically potentiate the function of the extracellular calcium-sensing receptor through distinct sites. J Biol Chem. 2002 277 : 33736 41.
74. 2+ and a positive allosteric modulator. J Biol Chem. 2002 277 : 46622 31.
75. Gowen M, Stroup GB, Dodds RA, James IE, Votta BJ, Smith BR, Bhatnagar PK, Lago AM, Callahan JF, DelMar EG, Miller MA, Nemeth EF, Fox J. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest. 2000 105 : 1595 604.
76. Dvorak MM, Siddiqua A, Ward DT, Carter DH, Dallas SL, Nemeth EF, Riccardi D. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci USA. 2004 101 : 5140 5.
77. Arey BJ, Seethala R, Ma Z, Fura A, Morin J, Swartz J, Vyas V, Yang W, Dickson JK Jr., Feyen JH. A novel calcium-sensing receptor antagonist transiently stimu-lates parathyroid hormone secretion in vivo. Endocrinology. 2005 146 : 2015 22.
78. Yang W, Wang Y, Roberge JY, Ma Z, Liu Y, Michael Lawrence R, Rotella DP, Seethala R, Feyen JH, Dickson JK Jr. Discovery and structure-activity relationships of 2-benzylpyrrolidine-substituted ary-loxypropanols as calcium-sensing receptor antagonists. Bioorg Med Chem Lett. 2005 15 : 1225 8.
79. Gavai AV, Vaz RJ, Mikkilineni AB, Roberge JY, Liu Y, Lawrence RM, Corte JR, Yang W, Bednarz M, Dickson JK Jr., Ma Z, Seethala R, Feyen JH. Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists. Bioorg Med Chem Lett. 2005 15 : 5478 82.
80. 2+ receptor converts a negative allosteric modulator into a positive allosteric modulator. J Biol Chem. 2006 281 : 21558 65.